Projects per year
Personal profile
Education
- 2014-2020- Ph.D., Institute of Clinical Medicine, National Yang-Ming University
- 2000-2007 M.D., Faculty of Medicine, National Yang-Ming University
Experience
- 2020.07- Assistant Professor, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University
- 2020.01- Director, Taiwan Hypertension Society (THS)
- 2016.11 Attending Physician, Division of Cardiology, Department of Internal Medicine, Taipei Medical University Hospital
- 2014.08-2020.07 Adjunct Instructor, National Yang-Ming University
- 2014.07-2016.07 Attending Physician, Taipei Veterans General Hospital
Fingerprint
Dive into the research topics where Chien-Yi Hsu is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
研究第14 腫瘤壞死因子（TNFSF14）對粥狀動脈硬化進展、血管內皮功能及心血管疾病之影響– 從基礎到臨床
8/1/21 → 7/31/22
Project: A - Government Institution › b - Ministry of Science and Technology
-
The protective mechanisms of low-dose carbon monoxide against oxidative stress-mediated inflammation in the pathogenesis of abdominal aortic aneurysm
5/1/21 → 4/30/22
Project: C - Project of Alliance › p - Taipei Medical University Hospital
-
The mechanisms and therapy of ambient air particulate mattermediated vascular inflammation
5/1/20 → 4/30/21
Project: C - Project of Alliance › p - Taipei Medical University Hospital
-
Carbon monoxide releasing molecule-2 attenuates angiotensin II-induced IL-6/Jak2/Stat3-associated inflammation by inhibiting NADPH oxidase- and mitochondria-derived ROS in human aortic smooth muscle cells
Hsu, C. Y., Vo, T. T. T., Lee, C. W., Chen, Y. L., Lin, W. N., Cheng, H. C., Vo, Q. C. & Lee, I. T., Apr 2022, In: Biochemical Pharmacology. 198, 114978.Research output: Contribution to journal › Article › peer-review
4 Citations (Scopus) -
Different left ventricular remodelling patterns and clinical outcomes between non-ischaemic and ischaemic aetiologies in heart failure patients receiving sacubitril/valsartan treatment
Lee, Y. H., Chiou, W. R., Hsu, C. Y., Lin, P. L., Liang, H. W., Chung, F. P., Liao, C. T., Lin, W. Y. & Chang, H. Y., Mar 1 2022, In: European Heart Journal - Cardiovascular Pharmacotherapy. 8, 2Research output: Contribution to journal › Article › peer-review
13 Citations (Scopus) -
Assessing the facilities and healthcare services for heart failure: Taiwan versus European countries
Chang, H. Y., Hung, P. L., Liao, C. T., Hsu, C. Y., Liao, Y. C., Lu, K. H. & Wang, C. C., 2021, (Accepted/In press) In: Journal of the Formosan Medical Association. 121, 1, p. 258-268 11 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Association of multiple preventive therapies postdischarge and long-term health outcomes after acute myocardial infarction
Chen, C. W., Lin, Y. C., Shih, C. M., Chen, W. T., Lin, F. Y., Bi, W. F., Kao, Y. T., Chiang, K. H., Chan, C. S., Hsu, C. Y., Yang, T. L., Hsiao, C. Y., Hsiao, B. Y., Chien, L. N. & Huang, C. Y., Dec 1 2021, In: Journal of the Chinese Medical Association : JCMA. 84, 12, p. 1084-1091 8 p.Research output: Contribution to journal › Article › peer-review
Open Access3 Citations (Scopus) -
Carbon Monoxide-Releasing Molecule-2 Ameliorates Particulate Matter-Induced Aorta Inflammation via Toll-Like Receptor/NADPH Oxidase/ROS/NF- κ B/IL-6 Inhibition
Vo, T. T. T., Hsu, C. Y., Wee, Y., Chen, Y. L., Cheng, H. C., Wu, C. Z., Lin, W. N. & Lee, I. T., 2021, In: Oxidative Medicine and Cellular Longevity. 2021, 2855042.Research output: Contribution to journal › Article › peer-review
Open Access2 Citations (Scopus)